Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -163,440 | -161,095 | -123,145 | -111,518 | -46,732 |
| Depreciation Amortization | 63,658 | 34,988 | 11,790 | 306 | 54 |
| Income taxes - deferred | -235 | 80 | 90 | 700 | N/A |
| Accounts receivable | -2,910 | -1,580 | -2,822 | -834 | N/A |
| Other Working Capital | -14,996 | -7,943 | -35,577 | 2,554 | 6,406 |
| Other Operating Activity | 24,434 | 48,946 | 22,207 | 27,791 | 5,953 |
| Operating Cash Flow | $-93,489 | $-86,604 | $-127,457 | $-81,001 | $-34,319 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -11,508 | 0 |
| PPE Investments | -1,257 | -2,074 | -2,777 | -1,489 | -346 |
| Sale Of Investment | N/A | N/A | 11,508 | N/A | N/A |
| Investing Cash Flow | $-1,257 | $-2,074 | $8,731 | $-12,997 | $-346 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 125,000 | N/A | N/A |
| Common Stock Issued | 76,866 | 198 | 119,747 | 112,586 | 75,684 |
| Common Stock Repurchased | -302 | N/A | -15 | N/A | N/A |
| Other Financing Activity | -102 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $76,462 | $198 | $244,732 | $112,586 | $75,684 |
| Beginning Cash Position | 111,810 | 200,290 | 74,284 | 55,696 | 14,677 |
| End Cash Position | 93,526 | 111,810 | 200,290 | 74,284 | 55,696 |
| Net Cash Flow | $-18,284 | $-88,480 | $126,006 | $18,588 | $41,019 |
| Free Cash Flow | |||||
| Operating Cash Flow | -93,489 | -86,604 | -127,457 | -81,001 | -34,319 |
| Capital Expenditure | -1,257 | -2,074 | -2,777 | -1,489 | -346 |
| Free Cash Flow | -94,746 | -88,678 | -130,234 | -82,490 | -34,665 |